Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia



Status:Archived
Conditions:Blood Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:June 2010

Use our guide to learn which trials are right for you!

The TOPAZ Study: A Long-Term Extension Study in Elderly Subjects With Relapsed/Refractory Acute Myeloid Leukemia to Allow Continued Therapy With Tosedostat


The purpose of this study is to evaluate the long-term efficacy and safety profile of
tosedostat in elderly patients suffering from refractory or relapsed Acute Myeloid Leukemia.


Extension protocol to the OPAL Study (CHR-2797-038).

Study mimics normal clinical practice; few procedures and visits are therefore mandated by
the protocol. Timing of bone marrow assessment is also left at the investigator's
discretion.


We found this trial at
2
sites
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health Systems The University of Michigan is home to one of the...
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials